Vitrolife : Making the right choice - the importance of streamlined embryo evaluation
December 17, 2018 at 05:45 am EST
Share
Since the early days of human IVF, the quality of an embryo has been based on morphological or developmental characteristics that are assessed at defined time-points. With the introduction of time-lapse technology, we are now able to get the full picture of the dynamic embryo development and make full use of the long-standing existing embryological knowledge. In this recorded webinar, Dr. Tine Qvistgaard Kajhøj will guide you through the benefits of streamlined embryo evaluation, how to perform it and how it helps you obtain improved results.
Which risks does traditional embryo evaluation carry?
Things to consider in order to improve the embryo evaluation process
Benefits of streamlining embryo evaluation
How to approach streamlining
Tools to support your streamlining process
Watch webinar
Attachments
Original document
Permalink
Disclaimer
Vitrolife AB published this content on 17 December 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 17 December 2018 10:44:07 UTC
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Companyâs product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
VITROLIFE AB 
